LEADER 04069nam 2200661 a 450 001 9910807170403321 005 20240516151550.0 010 $a9786613769954 010 $a9781280998348 010 $a1280998342 010 $a9781118347850 010 $a1118347854 010 $a9781118347867 010 $a1118347862 010 $a9781118347836 010 $a1118347838 035 $a(CKB)2670000000209398 035 $a(EBL)894396 035 $a(OCoLC)798534225 035 $a(SSID)ssj0000678964 035 $a(PQKBManifestationID)11396070 035 $a(PQKBTitleCode)TC0000678964 035 $a(PQKBWorkID)10737742 035 $a(PQKB)11365252 035 $a(MiAaPQ)EBC894396 035 $a(Au-PeEL)EBL894396 035 $a(CaPaEBR)ebr10580148 035 $a(CaONFJC)MIL376995 035 $a(PPN)178684562 035 $a(Perlego)1013375 035 $a(EXLCZ)992670000000209398 100 $a20120117d2012 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aResolving erroneous reports in toxicology and therapeutic drug monitoring $ea comprehensive guide /$fAmitava Dasgupta 205 $a1st ed. 210 $aHoboken, N.J. $cJohn Wiley & Sons$dc2012 215 $a1 online resource (467 p.) 300 $aDescription based upon print version of record. 311 08$a9781118149652 311 08$a1118149653 320 $aIncludes bibliographical references and index. 327 $aAn introduction to tests performed in toxicology laboratories and methodologies available for such testings -- Challenges in drugs of abuse testing -- False positive results in immunoassays for drugs of abuse testing -- True positive drugs of abuse test results due to prescription and non-prescription drugs -- When toxicology report is negative in a suspected overdosed patient : the world of designer drugs -- Abuse of magic mushroom, peyote cactus and solvent : no readily available laboratory tests -- False positive alcohol tests using breath analyzers and automated analyzers -- Role of laboratory in detecting other poisoning including pesticides, ethylene glycol, and methanol -- Poisoning with warfarin and superwarfarin : what laboratory can do? -- Plant poisoning and clinical laboratory -- Sources of erroneous results in therapeutic drug monitoring due to pre-analytical errors, high bilirubin, hemolysis, and heterophilic antibody -- Interferences in immunoassays used for digoxin monitoring -- Interferences in immunoassays used for monitoring anticonvulsants and usefulness of monitoring free anticonvulsants in certain patients -- Interferences in immunoassays used for monitoring tricyclic antidepressant -- Therapeutic drug monitoring of immunosuppressant drugs : limitations of immunoassays and need for chromatographic methods -- Effect of drug-herb interactions on therapeutic drug monitoring -- Pharmacogenomics and toxicology laboratory -- Approaches for eliminating interference/discordant specimen in therapeutic drug monitoring and drugs of abuse testing. 330 $a The tools for detecting false positives, false negatives, and interference in interactions when testing and monitoring therapeutic drug use For physicians monitoring a patient's progress, efficacy of treatment is often linked to a patient's response to medication. Determining whether a patient is taking the prescribed amount, the drug or dosage is effective, or the prescribed medication is interacting with other drugs can be determined through drug testing. Written as a guide for toxicologists, chemists, and health professionals involved in patient care, Resolving Erroneous 606 $aDrug monitoring 615 0$aDrug monitoring. 676 $a615.7/040724 700 $aDasgupta$b Amitava$f1958-$0867120 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910807170403321 996 $aResolving erroneous reports in toxicology and therapeutic drug monitoring$94080249 997 $aUNINA